Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonny Peter

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Allergy and Clinical Immunology. Global|July 1, 2024
Advanced human immunodeficiency virus (HIV) does not affect ability to utilize lymphadenopathy in assessment of drug reaction with eosinophilia and systemic symptoms syndrome in HIV and tuberculosis: Prospective comparative studyMusonda Sharon Machona, Rudzani Muloiwa, Mireille Porter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 28, 2023
Stevens-Johnson syndrome and toxic epidermal necrolysis-associated dysgeusia: Natural history and association with dysosmiaRupesh Misra, Gail Todd, Julie Esterhuizen, et al.
The Lancet. Infectious Diseases|January 21, 2014
Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?Grant Theron, Jonny Peter, David Dowdy, et al.
BMC Palliative Care|November 15, 2019
The utility of a shortened palliative care screening tool to predict death within 12 months - a prospective observational study in two south African hospitals with a high HIV burdenPeter J Raubenheimer, Cascia Day, Faried Abdullah, et al.
The Cochrane Database of Systematic Reviews|September 9, 2016
GenoType<sup>®</sup> MTBDRsl assay for resistance to second-line anti-tuberculosis drugsGrant Theron, Jonny Peter, Marty Richardson, et al.
Nature Reviews. Disease Primers|September 15, 2022
UrticariaPavel Kolkhir, Ana M Giménez-Arnau, Kanokvalai Kulthanan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 25, 2020
Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposureRannakoe J Lehloenya, Thuraya Isaacs, Tonderai Nyika, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 17, 2026
Advancing Penicillin Allergy Models of Care: An observational study comparing the safety of non-allergist and allergist-led low-risk adult penicillin allergy delabellingNeil Powell, Sara Vogrin, Jonny Peter, et al.
Plos One|May 26, 2012
Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden settingGrant Theron, Jonny Peter, Laura Lenders, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 4, 2026
Blistering Drug Eruptions: Diagnostic Challenges and Management in Clinical Practice Unmasking the Cause: A Grand Rounds Review of Blistering Drug EruptionAna Maria Copaescu, Michael Ardern-Jones, Natalie K Hickerson, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Allergy and Clinical Immunology. Global|July 1, 2024
Advanced human immunodeficiency virus (HIV) does not affect ability to utilize lymphadenopathy in assessment of drug reaction with eosinophilia and systemic symptoms syndrome in HIV and tuberculosis: Prospective comparative studyMusonda Sharon Machona, Rudzani Muloiwa, Mireille Porter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 28, 2023
Stevens-Johnson syndrome and toxic epidermal necrolysis-associated dysgeusia: Natural history and association with dysosmiaRupesh Misra, Gail Todd, Julie Esterhuizen, et al.
The Lancet. Infectious Diseases|January 21, 2014
Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?Grant Theron, Jonny Peter, David Dowdy, et al.
BMC Palliative Care|November 15, 2019
The utility of a shortened palliative care screening tool to predict death within 12 months - a prospective observational study in two south African hospitals with a high HIV burdenPeter J Raubenheimer, Cascia Day, Faried Abdullah, et al.
The Cochrane Database of Systematic Reviews|September 9, 2016
GenoType<sup>®</sup> MTBDRsl assay for resistance to second-line anti-tuberculosis drugsGrant Theron, Jonny Peter, Marty Richardson, et al.
Nature Reviews. Disease Primers|September 15, 2022
UrticariaPavel Kolkhir, Ana M Giménez-Arnau, Kanokvalai Kulthanan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 25, 2020
Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposureRannakoe J Lehloenya, Thuraya Isaacs, Tonderai Nyika, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 17, 2026
Advancing Penicillin Allergy Models of Care: An observational study comparing the safety of non-allergist and allergist-led low-risk adult penicillin allergy delabellingNeil Powell, Sara Vogrin, Jonny Peter, et al.
Plos One|May 26, 2012
Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden settingGrant Theron, Jonny Peter, Laura Lenders, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 4, 2026
Blistering Drug Eruptions: Diagnostic Challenges and Management in Clinical Practice Unmasking the Cause: A Grand Rounds Review of Blistering Drug EruptionAna Maria Copaescu, Michael Ardern-Jones, Natalie K Hickerson, et al.
Pageof 11